Urinary oxalate excretion by very low birth weight infants receiving parenteral nutrition.

Abstract

Renal calcifications have been described in very low birth weight (VLBW) infants, and diuretic drug-associated hypercalciuria is believed to play a role in the pathogenesis of this lesion. Hyperoxaluria is an important cause of renal stone formation in children and adults. Because parenteral nutrition solutions contain the oxalate precursors ascorbate and glycine, the relationship between total parenteral nutrition administration and oxalate excretion in VLBW infants was examined. Administration of approximately 0.5 g of total parenteral nutrition protein per kilogram per day to VLBW infants was associated with an increased urinary oxalate concentration and an increased urinary oxalate to creatinine ratio, when compared with VLBW infants receiving a glucose and electrolyte solution. A further increase in urinary oxalate concentration and oxalate to creatinine ratio was noted when total parenteral nutrition protein was increased to approximately 1.5 g of protein per kilogram per day. In VLBW infants who receive total parenteral nutrition, elevated urinary oxalate concentrations may develop and may be a factor in the pathogenesis of nephrocalcinosis in these infants.

• Authors: T Campfield, G Braden
• Journal: Pediatrics (Pediatrics) Vol. 84 Issue 5 Pg. 860-3 (Nov 1989) ISSN: 0031-4005 [Print] United States
• PMID: 2508054 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Amino Acids
• Electrolytes
• Oxalates
• Parenteral Nutrition Solutions
• Solutions
• amino-acid, glucose, and electrolyte solution
• Creatinine
• Glucose
• Calcium

Topics

• Amino Acids (administration & dosage)
• Calcium (urine)
• Creatinine (urine)
• Electrolytes (administration & dosage)
• Glucose (administration & dosage)
• Humans
• Infant, Low Birth Weight (urine)
• Infant, Newborn
• Oxalates (urine)
• Parenteral Nutrition Solutions
• Parenteral Nutrition, Total (adverse effects)
• Solutions